enVVeno Medical Corporation

NVNO Healthcare Medical Devices

In the quarter to June 2026, EPS grew 53.6% and free cash flow grew 4.60%, each against the same quarter a year earlier.

7.47 0.46 −5.80%
Market cap
$5.5M
P/E
0.0×
Fwd P/E
−0.7×
Dividend yield
—
F-score
3/9
Altman Z
−28.30
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
13.12 13.58 11.89 11.70
Net Debt/EBITDA
6.50 7.24 6.33 5.70
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(7.65) (5.85) (4.95) (5.29)
Book value per Share
51.27 46.06 36.31 30.80
Free Cash Flow
(4.39) (3.44) (3.24) (3.55)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates